Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
NCT00760370
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Breast Cancer
Interventions
DRUG:
Zoledronic Acid
Sponsor
Vejle Hospital
Collaborators
[object Object]
[object Object]